Qualification and Verification of Serological Biomarker Candidates for Lung Adenocarcinoma by Targeted Mass Spectrometry

NCU Institutional Repository > 總教學中心委員會 > 通識教育中心 > 期刊論文 > Item 987654321/105823

請使用永久網址來引用或連結此文件: https://ir.lib.ncu.edu.tw/handle/987654321/105823

題名:	Qualification and Verification of Serological Biomarker Candidates for Lung Adenocarcinoma by Targeted Mass Spectrometry
作者:	吳忻怡;Wu, Hsin-Yi;Goan, Yih-Gang;Chang, Ying-Hua;Yang, Yi-Fang;Chang, Hsiao-Jen;Cheng, Pin-Nan;Wu, Chih-Chieh;Zgoda, Victor G;Chen, Yu-Ju;Liao, Pao-Chi
貢獻者:	總教學中心通識教育中心
關鍵詞:	adenocarcinoma;Adenocarcinoma - blood;Adenocarcinoma - diagnosis;Adenocarcinoma - metabolism;Aged;Aged, 80 and over;Amino Acid Sequence;biomarkers;Biomarkers, Tumor - blood;Biomarkers, Tumor - metabolism;Blood Proteins - analysis;Blood Proteins - metabolism;Female;Humans;lung neoplasms;Lung Neoplasms - blood;Lung Neoplasms - diagnosis;Lung Neoplasms - metabolism;lungs;Male;mass spectrometry;Mass Spectrometry - methods;Middle Aged;Molecular Sequence Data;mortality;Neoplasm Staging;patients;peptides;Peptides - blood;Peptides - metabolism;proteins;proteome;Proteomics - methods;Reproducibility of Results;Sensitivity and Specificity;therapeutics
日期:	2015-01-01
上傳時間:	2026-04-23 12:55:17 (UTC+8)
出版者:	American Chemical Society;United States: American Chemical Society
摘要:	摘要： Lung cancer is the leading cause of cancer mortality worldwide. Although many biomarkers have been identified for lung cancer, their low specificity and sensitivity present an urgent need for the identification of more candidate biomarkers. In this study, we conducted MRM-based targeted analysis to evaluate the potential utility of a list of candidate proteins for lung cancer diagnosis. A total of 1249 transitions of 420 peptides representing 102 candidate proteins from our previous study and the literature were first screened by MRM analysis in pooled plasma samples, resulting in 78 proteins remaining in the list. Relative quantification of these 78 proteins was further performed in 60 individual plasma samples from lung adenocarcinoma patients in stages I–III and matched healthy control subjects. Ultimately, nine proteins were found to be able to distinguish patients from controls. Further combinations of five, three, and two candidate marker proteins improved the sensitivity to discriminate patients from controls and resulted in a merged AUC value of nearly 1.00 in stages I–III patients versus controls. Our results highlighted several possible markers for lung adenocarcinoma, and the proposed protein panels require further validation in a larger cohort to evaluate their potential use in clinical applications or development of therapeutics. 其他題名： J. Proteome Res 出版者： United States: American Chemical Society 出版日期： 2015-08-07 出處： Journal of proteome research, 2015-08, Vol.14 (8), p.3039-3050 資源來源： American Chemical Society Journals 版權： Copyright © American Chemical Society 識別號： ISSN: 1535-3893 識別號： ISSN: 1535-3907 識別號： EISSN: 1535-3907 識別號： DOI: 10.1021/pr501195t 識別號： PMID: 26120931
顯示於類別:	[通識教育中心] 期刊論文

文件中的檔案:

檔案	描述	大小	格式	瀏覽次數
index.html		0Kb	HTML	27	檢視/開啟

在NCUIR中所有的資料項目都受到原著作權保護.

社群 sharing

資料載入中.....